CancerDrs

Pancreatic Cancer

One of the most aggressive cancers. Clinical trials are often the most direct path to access promising new therapies.

13.3%
5-year relative survival
U.S. average across all stages
300
recruiting trials
Active in the U.S. right now
67,440
new diagnoses / year
You are not alone — roughly 185 people per day
71
median age at diagnosis
Most diagnoses occur in adults over age 50

Source: NCI SEER + ClinicalTrials.gov

Pancreatic Cancer by the numbers (U.S.)

67,440
Estimated new cases (2025)
51,980
Estimated deaths (2025)
13.3%
5-year relative survival
71
Median age at diagnosis

Source: NCI SEER Cancer Stat Facts

Pancreatic Cancer clinical trials →

300 actively recruiting trials across the U.S., with filters by state.

FDA-approved drugs & cost →

Every FDA-approved therapy with pancreatic cancer in its indications — mechanisms, Medicare spending per drug, manufacturer assistance.

Drug costs overview →

CMS Medicare spending data for 15 major oncology drugs — what patients and Medicare actually pay.

Second opinion for pancreatic cancer →

Step-by-step for getting a virtual second opinion from a top cancer center.

NCI-designated cancer centers →

All 71 NCI cancer centers with hospital quality data and state browser.

Find a medical oncologist →

Licensed oncologists across every U.S. state, by specialty.

Financial aid resources →

Co-pay relief, drug patient-assistance, transportation, and lodging support.

Patient guides →

How to read a pathology report, questions to ask your oncologist, staging explained.

Also known as

pancreatic adenocarcinoma, PDAC.

For deeper statistics

See the NCI SEER Cancer Stat Facts page: Pancreatic Cancer on SEER →